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Abstract
Background: Hancornia speciosa Gomes (Apocynaceae), popularly known as “mangabeira,” has been used in folk
medicine to treat inflammatory disorders, hypertension, dermatitis, diabetes, liver diseases and gastric disorders.
Although the ethnobotany indicates that its fruits can be used for the treatment of ulcers and inflammatory
disorders, only few studies have been conducted to prove such biological activities. This study investigated the
anti-inflammatory properties of the aqueous extract of the fruits of H. speciosa Gomes as well as its bioactive
compounds using in vivo experimental models.
Methods: The bioactive compounds were identified by High Performance Liquid Chromatography coupled with
diode array detector (HPLC-DAD) and Liquid Chromatography coupled with Mass Spectrometry (LC-MS). The anti-
inflammatory properties were investigated through in vivo tests, which comprised xylene-induced ear edema,
carrageenan-induced peritonitis and zymosan-induced air pouch. The levels of IL-1β, IL-6, IL-12 and TNF-α were
determined using ELISA.
Results: Rutin and chlorogenic acid were identified in the extract as the main secondary metabolites. In addition,
the extract as well as rutin and chlorogenic acid significantly inhibited the xilol-induced ear edema and also
reduced the cell migration in both carrageenan-induced peritonitis and zymosan-induced air pouch models.
Reduced levels of cytokines were also observed.
Conclusion: This is the first study that demonstrated the anti-inflammatory activity of the extract of H. speciosa
fruits against different inflammatory agents in animal models, suggesting that its bioactive molecules, especially
rutin and chlorogenic acid are, at least in part, responsible for such activity. These findings support the widespread
use of Hancornia speciosa in popular medicine and demonstrate that its aqueous extract has therapeutical potential
for the development of herbal drugs with anti-inflammatory properties.
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Background
The use of plants is a common practice in Brazil’s folk
medicine and it has been based on the build-up of em-
pirical knowledge by various ethnic groups about the
therapeutic effect of these herbal plants [1]. These medi-
cinal plants are widely used for research of new drugs as
they represent a rich source of compounds with pharma-
cological properties [2]. Since these plants are naturally
found in relative abundance in Brazil, the population has
easy access to these natural sources at relatively low cost
and minimal side effects [3].
Hancornia speciosa Gomes, which belongs to the fam-
ily of Apocynaceae and is popularly known as “manga-
beira”, is a fruit plant species native to Brazil [4]. It is
found in the cerrado, caatinga and savanna vegetation
[5]. In traditional medicine, its fruits have been used to
treat ulcers, tuberculosis and inflammatory disorders [6],
whereas the infusion of barks have been used for treat-
ing gastric ulcers, stomach disturbances and inflamma-
tory processes [7]. In addition, its roots and leaves are
used to treat high blood pressure and rheumatism [8, 9].
Hancornia speciosa leaves have been demonstrated to
exhibit anti-hypertensive [10–12], anti-carcinogenic [13, 14]
and anti-diabetic properties [15]. Its barks have a marked
gastroprotective effect and anti-Helicobacter pylori activity
[16, 17]. However, there have been few studies that re-
ported the pharmacological effects of Hancornia speciosa
fruits and just recently, a group described the antimuta-
genic potential of its fruit pulp [18]. Its latex has shown
anti-inflammatory effect through reduction of edema in-
duced by bradykinin, histamine and serotonin, as well as
by inhibiting inflammation induced by subcutaneous car-
rageenan injection and through inhibition of leukocytes
migrations, nitric oxide, PGE2 and cytokines production
in mice [19]. Therefore, the anti-inflammatory effect of
Hancornia speciosa latex corroborated the popular use of
its fruits for the treatment of ulcers and inflammatory
disorders.
Inflammation is an immune system response triggered
by different stimuli, including chemical, physical and
biological [20]. The recognition of a harmful agent or
stimulus triggers the activation and amplification of the
immune response, resulting in cell activation and release
of various mediators responsible for the inflammatory
response [21]. Among these mediators, cytokines (IL-1β,
IL-6, IL-12 and TNF-α) are noteworthy as they are re-
sponsible for inducing the expression of adhesion mole-
cules and for inducing leukocytes sequestration from the
blood stream towards the inflammation site [22]. There-
fore, when the inflammatory process is not controlled, it
can cause tissue damage [23]. In order to control the
inflammation process, drugs that inhibit this clinical
condition, such as non-steroidal anti-inflammatory and
steroidal anti-inflammatory drugs are used. However, the
overuse of non-steroidal anti-inflammatory drugs can
cause side-effects such as gastrointestinal and cardiovas-
cular complications [24], whereas the steroidal anti-
inflammatory drugs may cause reduced resistance to
infections, aggravation of ulcers and osteoporosis [25].
On the other hand, studies have shown that plants are
able to reduce the inflammatory process with consider-
ably less side-effects. For instance, some vegetal extracts
are able to reduce the total number of leukocytes, to de-
crease the secretion of cytokines and histamine, as well
as to reduce the proliferation of lymphocytes [26, 27].
Given the importance of these biological properties,
traditional medicinal knowledge along with modern
techniques have optimized the process of drug discovery
from medicinal plants [28, 29].
Based on the fact that only few studies have reported
the pharmacological properties of H. speciosa fruits, des-
pite its widespread popular use as an anti-inflammatory
agent, this work aims to investigate the chemical constit-
uents of these fruits and associate its major compounds
with the anti-inflammatory effect. Therefore, phyto-
chemical analysis of the aqueous extract of the fruits of
H. speciosa was performed in order to identify the bio-
active compounds, followed by the evaluation of its anti-
inflammatory activity in experimental models using
mice. The in vivo models were the (i) carrageenan-
induced peritonitis, (ii) xylene-induced ear edema, and
(iii) zymosan-induced air pouch model, where the (iv)
production of cytokines (IL-1β, IL-6, IL-12 and TNF-α)
was also evaluated. To the best of our knowledge, this is
the first study that investigated the anti-inflammatory ef-
fect of the extract of the fruits of H. speciosa.
Methods
Plant material
The mature fruits were collected at Barra do Punaú re-
gion (lat:-5,34527 long:-35,41666), Rio do Fogo City, Rio
Grande do Norte, Brazil, in March of 2011 and was
identified by botanist Dr. Jomar Gomes Jardim. A voucher
specimen (UFRN 16880) was deposited in the Herbarium
of the Federal University of Rio Grande do Norte, Brazil.
The collection of the plant material was conducted under
authorization of the Brazilian Authorization and Biodiver-
sity Information System (SISBIO) (process number 35017)
and Brazilian Access Authorization and Dispatch Compo-
nent of Genetic Patrimony (Process 010844/2013-9).
Preparation of the aqueous extract
Fresh fruits (500 g) were sliced in pieces and submitted
to extraction by decoction using hot water at 100 °C
(1:10, w:v, plant:solvent) for 15 min. Further, the extract
was filtered through Whatman paper no.1 and lyophi-
lized. The final dried mass was 2.5 g (yield around
0.5 %).
Torres-Rêgo et al. BMC Complementary and Alternative Medicine  (2016) 16:275 Page 2 of 10
High Performance Liquid Chromatography coupled with
diode array (HPLC-DAD) Analysis
Analyses were performed using HPLC Varian® Pro Star
335 with diode array detector. A Phenomenex® RP-18
column (250 x 4.6 mm, 5 μm) was used. The eluents
were: (A) acetonitrile and (B) water with 0.3 % acetic
acid, with the following gradient (v/v): 13 %, 0–5 min
(B); 13–18 %, 5–25 min (B); 18–20 %, 25–30 min (B);
20–21 %, 30–35 min (B). Flow elution was 0.7 mL/min
and 20 μL of each sample was injected. The lyophilized
extract and standard solutions were resuspensed in
methanol: water, 1:1 (v/v) and the final concentrations
were 5 mg/mL and 50 μg/mL. The chromatogram was
visualized in 270 and 340 nm, where each peak and their
retention time (Rt) was compared with those of the stan-
dards. The peaks that showed similar UV and Rt were
analyzed by co-injection (reference standard + extract)
with the purpose of observing any increase in the peak
area. Samples and solvents were previously filtered
through a 0.45 μm membrane and degassed. Both rutin
(purity 94 %) and chlorogenic acid (purity 95 %) were
purchased from Sigma-Aldrich®, USA.
Liquid Chromatography coupled with mass spectrometry
(LC-MS) analysis
High resolution analyses by LC-MS were performed on a
Shimadzu LC-20 AD apparatus equipped with an auto-
sampler (SIL-20A, Shimadzu), diode array detector (SPD-
M20AV, Shimadzu) and coupled with a micrOTOFII
(Bruker Daltonics) ESI-qTOF mass spectrometer. The LC
conditions were the same applied at High Performance Li-
quid Chromatography coupled with diode array (HPLC-
DAD) Analysis. The column eluent was split at a ratio of
7:3, where the larger flow went to the DAD detector and
the lower one went to the mass spectrometer.
Low resolution applied a similar Shimadzu LC-20 AD
apparatus coupled with an ESI-ion trap mass spectrom-
eter (amaZon, Bruker Daltonics). Again, the LC conditions
were the same as described on High Performance Liquid
Chromatography coupled with diode array (HPLC-DAD)
Analysis. The column eluent was split at a ratio of 7:3,
where the larger flow went to the DAD detector and the
lower one went to the mass spectrometer.
Animals
Male and female Swiss and BALB/c mice (25–35 g), 6–
8 weeks of age, were maintained at a temperature of
22 ± 2 °C and at a 12/12 h light/dark cycle. Each test
group was composed of five animals (n = 5). The experi-
mental protocol was approved by the Committee for
Ethics in Animal Experimentation of the Universidade
Federal do Rio Grande do Norte, Brazil, at the Protocol N°
008/2011 and in accordance with the guidelines of
National Council for the Control of Animal Experimenta-
tion (CONCEA).
Carrageenan-induced peritonitis model
Peritoneal inflammation was induced according to the
procedure previously described in [30] with few modifica-
tions. BALB/c mice were inoculated intravenously (i.v.)
with 100 μL of saline, aqueous extract of Hancornia spe-
ciosa fruits (20, 30 or 40 mg/kg), chlorogenic acid (2, 2.5
or 5 mg/kg) or rutin (2, 2.5 or 5 mg/kg), while dexametha-
sone was injected intraperitoneally (i.p.) (0.5 mg/kg) and
used as the anti-inflammatory reference drug. After
30 min, the animals received carrageenan (1 mg/mL) or
saline intraperitoneally. After 4 h, the animals were eutha-
nized with an overdose of xylazine and ketamine (10 mg/
kg–100 mg/kg) and peritoneal exudates were harvested by
peritoneal lavage using 2 mL of saline, followed by centri-
fugation at 250 g for 10 min at 4 °C. Leucocytes count was
determined using a Neubauer chamber [31, 32]. The su-
pernatants were collected for determination of IL-1β, IL-6,
IL-12 and TNF-α levels using an ELISA kit (eBioscience,
USA) following the manufacturer’s instructions.
Xylene-induced ear edema model
BALB/c mice were treated intraperitoneally with 100 μL
of saline, dexamethasone (0.5 mg/kg), aqueous extract of
Hancornia speciosa fruits (40, 50 or 60 mg/kg), rutin
(2.5, 5 or 10 mg/kg) and chlorogenic acid (10, 12.5 or
15 mg/kg). Thirty minutes after the treatment, all the
animals received 40 μL of xylene administered in the an-
terior and posterior surfaces of the right ear. The left ear
was taken as control where only saline was administered.
Fifteen minutes after xylene administration, the animals
were euthanized and both ears were cut off at circular
sections of 7 mm using a cork borer and then weighed
[33]. The edematous response was measured as the
weight difference between the right and left ears, where
the inhibition level was then calculated as:
Inhibition %ð Þ ¼ 1−Et=Ec½   100;
where Et and Ec are the average weight of the edemas in
the sample-treated and control groups, respectively.
Zymosan-induced air pouch model
Swiss mice received 5 mL of sterile air subcutaneously
(s.c.), which were injected into the back of the animals.
After three days, 2.5 mL of sterile air was injected into the
cavity. Six days after the initial air injection, the animals
received intraperitoneal injection of saline, dexamethasone
(2.0 mg/kg), aqueous extract of Hancornia speciosa fruits
(40, 50, or 60 mg/kg), rutin (2.5, 5 or 10 mg/kg) and
chlorogenic acid (10,12.5 or 15 mg/kg) [33]. After 30 min,
zymosan solution (1 mg/mL) was injected into the air
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pouch. At pre-determined time points (6, 24, and 48 h),
the animals were euthanized and exudates were harvested
from each air pouch by washing with 2 mL of saline. Leu-
cocytes count was determined using a Neubauer chamber
[34–36]. The cell pellet was diluted in 500 mL of saline
and the cell subpopulations count (polymorphonuclear
and mononuclear cells) was determined based on the
count of 100 cells using a hemocytometer [37].
Statistical analysis
Data are expressed as mean ± standard deviation. Statis-
tical analyses were performed by One-way ANOVA with
Tukey’s test and regression analyses were performed
using GraphPad Prism version 5.00 (San Diego, CA,
USA). A difference in the mean values of P < 0.05 was
considered as statistically significant.
Results
HPLC-DAD analysis
Analysis by HPLC-DAD showed the presence of chloro-
genic acid (peak 1) and rutin (peak 2) in the aqueous
extract of Hancornia speciosa fruit (Fig. 1). The standard
solutions of these compounds were analyzed, showing
retention times of 7.9 (solvent A: 87-82 %) and 25.5 min
(solvent A: 82-80 %), respectively, which are similar to
peaks 1 and 2. In addition, UV spectrum of peaks 1 and
2 exhibited UV λmax of 222 and 326 nm (peak 1) and
257 and 353 nm (peak 2), respectively, which were simi-
lar to the UV spectrum of chlorogenic acid and rutin.
Through the co-injection analysis of the standards and
the aqueous extract, an increase in the peak areas was
observed, confirming the presence of these compounds.
Although peak 3 was not identified, the UV spectrum
suggests it is due to the presence of an unidentified
phenolic acid (UV λmax 223 and 332 nm) [38].
LC-MS analysis
Peak 1 showed a retention time of 7.9 min, UV λmax of
222 and 326 nm, m/z (int.) [M +H]+ m/z 355,1035. The
compound 1 was identified as chlorogenic acid after a
comparison with the theoretical exact mass of the proton-
ated molecule (calculated as 355.1029, error 1,6 ppm). In
Fig. 1 HPLC-DAD chromatograms of the aqueous extract of the fruits of Hancornia speciosa. The analysis shows three major peaks, designated as peak
1 (Rt = 7.9 min, solvent A: 87-82 %), peak 2 (Rt = 25.5 min, solvent A: 82-80 %) and peak 3 (Rt = 28.5 min, solvent A: 82-80 %), which correspond to
chlorogenic acid, rutin and an unidentified phenolic acid compound, respectively. Stationary phase: column Phenomenex-Luna® C-18 (4.6 mm x
250 mm, 5 μm); mobile phase: gradient of acetonitrile: water with 0.3 % acetic acid; flow rate was kept constant at 1.0 ml/min; Detection UV of 340 nm
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addition, the protonated molecule afforded the typical
fragment ion [M+H-192]+ at m/z 163, which is attributed
to the loss of quinic acid moiety. The peak 2 showed a re-
tention time of 25.5 min, UV λmax of 257 and 353 nm, m/
z (int.) [M+H]+ m/z 611 (protonated molecule) and the
fragments atm/z 465 and 303. The compound 2 was iden-
tified as rutin and its exact mass was calculated as m/z
611.1607, (theoretical exact mass: 611.1612 error, 0,8 ppm).
The fragments were in agreement with the ion [M+H-
146]+ at m/z 465, which is attributed to the loss of
rhamnose moiety and a protonated aglycone ion [M+H-
146-162]+, whereas the loss of 308 u corresponds to a
rhamnose (146 u) plus a glucose (162 u) moiety. The LC-
MS analyses were compared with MassBank database
(http://www.massbank.jp).
Evaluation of rutin, chlorogenic acid and aqueous extract
of the fruits of Hancornia speciosa in carrageenan-
induced peritonitis model
The anti-inflammatory activity of the aqueous extract,
chlorogenic acid and rutin was evaluated using the
carrageenan-induced peritonitis model. As expected, the
animals treated intravenously (i.v.) with saline and thirty
minutes later with the intraperitoneal (i.p.) administra-
tion of carrageenan exhibited a severe cell migration to
the peritoneal cavity, as well as an increased production
of IL-1β, IL-6, IL-12 and TNF-α. All groups treated (i.v.)
with different doses (20, 30 or 40 mg/kg) of the extract,
rutin and chlorogenic acid at doses of 2, 2.5 or 5 mg/kg,
showed a significant inhibition of cell migration into the
peritoneal cavity when compared to those of the groups
treated with saline (i.v.) and carrageenan (i.p.) (Fig. 2a).
When only the extract (40 mg/kg) was administered
intravenously, without the injection of carrageenan, in-
flammation could not be induced. The different doses
(20, 30 or 40 mg/kg) of the extract, as well as rutin and
chlorogenic acid at doses of 2, 2.5 or 5 mg/kg, significantly
inhibited the production of cytokines IL-1β (Fig. 2b), IL-6
(Fig. 2c), IL-12 (Fig. 2d) and TNF-α (Fig. 2e). In addition,
the reduction in the total number of leukocytes and the
decrease in the production of cytokines in the group
treated with dexamethasone were very similar to those
treated with the extract, rutin and chlorogenic acid.
Evaluation of rutin, chlorogenic acid and the aqueous
extract of the fruits of Hancornia speciosa in xylene-
induced ear edema model
The effects of rutin, chlorogenic acid and extract on
edema formation in mice were investigated using xylene-
induced ear edema model. The groups treated (i.p.) with
40, 50 and 60 mg/kg of the extract showed a suppression
of the xylene-induced ear edema of 78.36, 81.07 and
73.18 %, respectively. These results were similar to those
of the group treated with dexamethasone (i.p.) at a dose of
0.5 mg/kg (79.66 %). When only the extract (60 mg/kg)
was administered intraperitoneally, without xylene, it was
observed that both ears showed similar weights, with the
right and left ears weighing 28.40 mg (±0.8540) and
27.50 mg (±1.067), respectively. These results suggest that
the aqueous extract alone is not able to induce the forma-
tion of edema. The group treated with rutin (i.p.) received
doses of 2.5, 5 and 10 mg/kg, which were able to reduce
the edema in 76.94, 83.29 and 97.78 %, respectively,
whereas the groups treated (i.p.) with chlorogenic acid
with doses of 10, 12.5 and 15 mg/kg showed a reduction
of 85.82, 83.17 and 79.84 % of the edema, respectively
(Table 1).
Evaluation of rutin, chlorogenic acid and the aqueous
extract of the fruits of Hancornia speciosa in zymosan-
induced air pouch model
After zymosan was injected into the animal’s air pouch,
acute inflammation was induced, whose response was
characterized by leukocyte migration and plasma exud-
ation to the cavity. Mice treated (i.p.) with saline and
thirty minutes later with subcutaneous (s.c.) administra-
tion of zymosan showed intense leukocyte migration to-
wards the animals’ pouch. However, all the groups
treated (i.p.) with different doses (40, 50 or 60 mg/kg) of
the extract showed a significant inhibition of leukocyte
migration compared with the group that received only
saline (i.p.) and zymosan (s.c.). When only the extract
(60 mg/kg) was administered intraperitoneally, without
receiving the injection of zymosan, it was observed that
cellular migration into the cavity was similar to that of
the saline group, which indicates that the extract alone
is not able to induce leukocytes migration and hence in-
flammation. The groups treated (i.p.) with rutin at doses
of 2.5, 5 and 10 mg/kg and chlorogenic acid at doses of
10, 12.5 and 15 mg/kg showed a significant inhibition of
cell migration (Fig. 3a).
After evaluating the effect of three different doses of
rutin, chlorogenic acid and extract, their effects on the
kinetics (6, 24 and 48 h) of cell migration and differential
count were evaluated using a fixed dose of each of these
compounds. The administration of zymosan (s.c.) in-
duced a marked increase in cell migration to the back of
the mice at all time points (6, 24 and 48 h). However,
the previous treatment with the aqueous extract (i.p.) at
a dose of 50 mg/kg, rutin (i.p.) at 2.5 mg/kg and chloro-
genic acid (i.p.) at 10 mg/kg was able to significantly in-
hibit leukocyte migration during all the time points,
which was in fact, very similar to that of the group
treated with dexamethasone (i.p.) at a dose of 2.0 mg/kg.
Thus, the treated-groups showed a marked decrease in
the leukocyte migration even 48 h after zymosan inocu-
lation (Fig. 3b). Furthermore, the extract (i.p.) at a dose
of 50 mg/kg, rutin (i.p.) at a dose of 2.5 mg/kg and
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chlorogenic acid (i.p.) at a dose of 10 mg/kg reduced the
number of polymorphonuclear cells at all time points (6,
24 and 48 h) (Fig. 3c). The number of mononuclear cells
was analyzed, but they did not show statistical difference
between groups (data not shown).
Discussion
In the present study, phytochemical analysis of the ex-
tract from the H. speciosa fruits indicated the presence
of chlorogenic acid and rutin (Fig. 1). The presence of
chlorogenic acid has also been demonstrated by [39],
where six phenolic acids (chlorogenic, ferulic, gallic, p-
coumaric, protocatechuic and vanillic acids) were identi-
fied by ultra performance liquid chromatography (UPLC)
in the Brazilian tropical fruits “mangaba” (H. speciosa
Gomes) and “umbu” (Spondias tuberosa Arruda Camara)
[39]. Rutin and chlorogenic acid have been used for their
pharmacological properties such as anti-oxidant, anti-
Fig. 2 Effect of the aqueous extract from the fruits of Hancornia speciosa, rutin and chlorogenic acid in carrageenan-induced peritonitis model. BALB/c
mice were treated (i.v.) with saline, aqueous extract at doses of 20, 30 or 40 mg/kg, rutin, chlorogenic acid at the dose of 2, 2.5 or 5 and with
dexamethasone (i.p.) at the dose of 0.5 mg/kg, thirty minutes after carrageenan (1 mg/mL) or saline (1 mL) administration (i.p). After 4 h, peritoneal
lavage with saline was performed and leucocytes count was performed using a Neubauer chamber (a). The supernatants were collected for the
determination of IL-1β (b), IL-6 (c), IL-12 (d), and TNF-α (e), which was performed using an enzyme-linked immunosorbent assay. The solid column
(black bar) represents the groups that received saline solution (i.v.) followed by intraperitoneal administration of carrageenan 30 min later. Each column
represents the mean of the values obtained from five animals, and the vertical lines indicate the standard errors of the mean (SEM). ###p < 0.001
compared with the group treated with saline; ***p< 0.001 compared with the carrageenan group. Sal: saline (0.9 mg/mL); Dx: dexamethasone (0.5 mg/kg)
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carcinogenic and anti-inflammatory [40–42]. Regarding
the anti-inflammatory activity of Hancornia speciosa,
there is one study that reported this property, but it was
performed on its latex [19] and for the best of our know-
ledge, no study has been performed on its fruits. Our
previous in vitro study demonstrated that different con-
centrations (0.25, 0.375, 0.5, 0.75, 1, 1.25 and 1.75 mg/mL)
of aqueous extracts from the fruits of Hancornia speciosa
did not present significant toxicity in 3 T3 cells. Thus, the
data suggest that the doses of H. speciosa extracts used in
this study are safe. The lack of cytotoxicity effect of Han-
cornia speciosa fruits was corroborated with the cytotox-
icity effects of H. speciosa latex on the root meristem cells
of Allium cepa [43].
Thus, the anti-inflammatory effects of the extract of
the H. speciosa fruits as well as rutin and chlorogenic
acid were evaluated using in vivo inflammatory models.
The carrageenan-induced peritonitis involves the acute
inflammation process that takes place through the re-
lease of histamine, serotonin and bradykinin, which lead
to an increase in the vascular permeability and prosta-
glandins production [44, 45]. The increased vascular
permeability and higher production of inflammatory me-
diators resulted in a gradual increase in fluid leakage
and a higher number of cells that migrated into the ani-
mal’s peritoneal cavity, especially neutrophils, which are
capable of producing cytokines that are associated with
the inflammatory process. If this process is not con-
trolled, it can cause serious infection that often leads to
multiple organ failure, septicemia and mortality [46].
This study showed that the aqueous extract, rutin and
chlorogenic acid exerted an anti-inflammatory effect at
all tested doses. They were able to reduce cell recruit-
ment into the peritoneal cavity of mice and inhibited the
Fig. 3 Effect of the aqueous extract from the fruits of Hancornia
speciosa in zymosan-induced air pouch model. Swiss mice were treated
(i.p.) with saline, aqueous extract at doses of 40, 50 or 60, rutin,
chlorogenic acid at the dose of 2, 2.5 or 5 and with dexamethasone
(2.0 mg/kg), thirty minutes after subcutaneous (s.c.) injection of zymosan
solution (1 mg/mL) or saline (1 mL) into the animals air pouch. After six
hours, the exudate was harvested from each air pouch by lavage with
2 mL of saline and leucocytes count was performed using a Neubauer
chamber (a). At 6, 24 and 48 h after zymosan administration, the dose
of 50 mg/kg of aqueous extract, 2.5 mg/kg of rutin and 10 mg/kg
chlorogenic acid were chosen to perform the experiment of leucocytes
cell migration kinetics (b) and polymorphonuclear cells migration
kinetics (c). The solid column (black bar) represents the group that
received saline solution (i.p.) followed by subcutaneous administration
of zymosan 30 min later. Each column represents the mean of the
values obtained from five animals, and the vertical lines indicate the
standard errors of the mean (SEM). ###p < 0.001 compared with the
control group (Sal); ***p< 0.001, **p < 0.01 and *p < 0.05, compared with
the zymosan group (Zym). Sal: saline (0.9 mg/mL); Zym: zymosan
(1 mg/mL); Dx: dexamethasone (2.0 mg/kg); AE: aqueous extract
(50 mg/kg); RT: rutin (2.5 mg/kg); CA: chlorogenic acid (10 mg/kg)
Table 1 Anti-edematogenic effect of rutin, chlorogenic acid
and the aqueous extract from the fruits of Hancornia speciosa in
xylene-induced ear edema model
Groups (treatment i.p.) Dose (mg/kg) Difference (mg) Inhibition (%)
Saline —— 32.450 ± 2.603
Dexamethasone 0.5 6.600 ± 2.448*** 79.66
Aqueous extract 40 7.020 ± 3.820*** 78.36
Aqueous extract 50 6.140 ± 2.385*** 81.07
Aqueous extract 60 8.700 ± 2.719*** 73.18
Rutin 2.5 7.480 ± 2.221*** 76.94
Rutin 5 5.420 ± 2.328*** 83.29
Rutin 10 0.720 ± 1.253*** 97.78
Chlorogenic acid 10 4.600 ± 2.795*** 85.82
Chlorogenic acid 12.5 5.460 ± 2.579*** 83.17
Chlorogenic acid 15 6.540 ± 3.917*** 79.84
Values are mean ± standard deviation (S.D.), n = 5, ***p < 0.001, tested-group
compared to saline-treated group
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production of cytokines (IL-1β, IL-6, IL-12 and TNF-α).
The mechanism involved in their anti-inflammatory ac-
tivity is still unknown. However, there are hypotheses
that can be suggested. Considering that a vascular endo-
thelial cell contraction takes place at the moment of in-
jury, it is likely that an increase in vascular permeability
with the production of exudate eventually occurs. Such
vascular events induce the activation of inflammatory
mediators, followed by the recruitment and adhesion of
leukocytes to the inflammation site. These mechanisms
are regulated by both cell adhesion molecules and by the
production of inflammatory cytokines [21, 47]. There-
fore, it seems that the aqueous extract of H. speciosa
fruits and its bioactive molecules inhibited the inflam-
matory mediators involved in the carrageenan-induced
inflammation, such as histamine, serotonin, kinins and
prostaglandins, which are responsible for inducing vaso-
dilatation and formation of exudate in the peritoneal
cavity. In addition, they could have inhibited the leuko-
cytes receptors that connect with intercellular adhesion
molecules that activate endothelial cells, blocking the
migration of the leukocytes to the inflammation site. If
these inflammatory mediators and vascular events are
blocked or interrupted, the production of inflammatory
cytokines will also be compromised.
Induction of ear edema was used as the primary model
for acute inflammation, where xylene acted as the phlo-
gistic agent, increasing vascular permeability with edema
formation, which is one of the main signs of inflamma-
tion. This inflammation process is initiated by the action
of mediators such as serotonin, acetylcholine, histamine,
bradykinin and prostaglandins, which release neuropep-
tides that activate its receptors, causing neurogenic
inflammation [48]. One of the neuropeptides, called sub-
stance P, is a potent vasodilator that acts by releasing
nitric oxide from endothelial cells, which causes vaso-
dilatation and plasma exudation, inducing the formation
of edema [49]. In this study, it was demonstrated that
the extract, rutin and chlorogenic acid were able to re-
duce at least 73 % of the ear edema, which indicates a
promising anti-phlogistic effect. Although the mechan-
ism of action has not been elucidated, it seems that the
extract have a membrane-stabilizing effect that reduces
vasodilatation, as rutin reportedly improves the strength
and integrity of blood vessel walls [50]. The other possi-
bility is through an inhibitory effect over the inflamma-
tory mediators that activate receptors that cause the
neurogenic inflammation.
The zymosan-induced air pouch was another in vivo
model that was used in this study to investigate the anti-
inflammatory properties of the extract, rutin and chloro-
genic acid. Due to the fact that the injection of sterile air
into the back of an animal forms a cell-lined cavity that
resembles the synovial membrane, this model is considered
to be similar to the inflammatory response of synovial tis-
sue [36, 51]. Zymosan is a polysaccharide derived from
Saccharomyces cerevisiae yeasts, whose administration
promotes an intense inflammatory reaction [52]. The re-
sults revealed that rutin, chlorogenic acid and the extract
significantly reduced leukocytes migration to the pouch of
the mice at all time points, even after 48 h of zymosan ad-
ministration. In addition, significant reduction of poly-
morphonuclear cells, as well as an increase in the number
of mononuclear cells shows the ability of the extract to
control the inflammation by reducing the number of neu-
trophils at the inflammation site. The mechanism involved
in the inhibition of inflammation by this extract is still un-
clear. There are reports in the literature that indicate that
zymosan interacts with the toll-like receptor 2 (TLR-2).
Zymosan is recognized by receptors (dectin-1) present in
macrophages, neutrophils and T cells. After the recogni-
tion, it interacts with TLR-2. Studies suggest that the com-
bined signaling of dectin-1 and TLR-2 enhance the
responses triggered by each receptor [53]. This interaction
induces intracellular cascades that activates the selective
recruitment of adapter proteins and induces the myeloid
differentiation of gene 88 (MyD88), activating the tran-
scription of the nuclear factor kappa B (NF-kB), which is
responsible for the transcription of pro-inflammatory
genes, resulting in the production of inflammatory cyto-
kines and the expression of co-stimulatory molecules [54].
Previous reports have shown that rutin and chlorogenic
acid have several pharmacological activities, especially
anti-inflammatory [40, 42]. Recent studies show that both
chlorogenic acid and rutin inhibit the activation of NK-kB,
suppressing the production of prostaglandin E2 by inhibit-
ing the cyclooxygenase-2 expression [55, 56]. Thus, it
seems reasonable to consider that these two secondary
metabolites act synergically in this inflammation pathway.
Other possibility is that the extract or its bioactive molecules
can competitively inhibit the TLR-2 or/and dectin-1 recep-
tor, suppressing the intracellular cascades of inflammation.
Moreover, the inhibition of cell migration towards the
inflammation site can not be ruled out as another mech-
anism for the anti-inflammatory activity of Hancornia
speciosa fruits. It is known that the inflammatory process
occurs through the increase in the vascular permeability,
as well through the migration and activation of poly-
morphonuclear cells, especially neutrophils [57]. Thus, it
is possible that the bioactive molecules present in the
aqueous extract of Hancornia speciosa fruits bind to re-
ceptors of endothelial cells, inhibiting the cell migration
and the activation of inflammatory mediators involved in
chemotaxis and diapedesis.
Conclusion
In conclusion, these findings demonstrate for the first
time that the aqueous extract of the fruits of H. speciosa
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have a marked anti-inflammatory effect in animal
models. Moreover, these results suggest that rutin and
chlorogenic acid may play a critical role in controlling
inflammatory events, contributing, at least in part, for
the anti-inflammatory effect of H. speciosa fruits. How-
ever, additional studies are needed to show that other
constituents present in the extract also contribute to the
anti-inflammatory effect. Therefore, it seems reasonable
to suggest that the extract may represent in the near fu-
ture a new alternative or complementary option for
treating inflammatory disorders.
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